What does Dr. Belinda Schrooten, Neurochirurgie do?

Dr. Belinda Schrooten, Neurochirurgie is a specialist medical practice in Waasmunster. Private Limited, started on 17 December 2019, 1 establishment.

What is the address of Dr. Belinda Schrooten, Neurochirurgie?

The registered office of Dr. Belinda Schrooten, Neurochirurgie is located at Morgenster 7, 9250 Waasmunster.

Is Dr. Belinda Schrooten, Neurochirurgie still active?

Yes. According to the CBE (31 October 2026) Dr. Belinda Schrooten, Neurochirurgie is active, legal situation “Normale toestand”, started on 17 December 2019.

Is Dr. Belinda Schrooten, Neurochirurgie registered on Peppol?

Yes, Dr. Belinda Schrooten, Neurochirurgie is registered on the Peppol network with ID 0208:0739714179.

What is the enterprise number of Dr. Belinda Schrooten, Neurochirurgie?

The enterprise number of Dr. Belinda Schrooten, Neurochirurgie is BE0739714179.

When was Dr. Belinda Schrooten, Neurochirurgie founded?

Dr. Belinda Schrooten, Neurochirurgie was founded on 17 December 2019.

Who are the directors of Dr. Belinda Schrooten, Neurochirurgie?

According to the 2025 annual accounts, the directors of Dr. Belinda Schrooten, Neurochirurgie are: Belinda Schrooten.

Is Dr. Belinda Schrooten, Neurochirurgie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Belinda Schrooten, Neurochirurgie make in 2025?

Dr. Belinda Schrooten, Neurochirurgie posted a profit after taxes of € 28,385 in financial year 2025.

What is the revenue of Dr. Belinda Schrooten, Neurochirurgie?

As a small company, Dr. Belinda Schrooten, Neurochirurgie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 38,652.

Dr. Belinda Schrooten, Neurochirurgie (Private Limited)

Dossier Dr. Belinda Schrooten, Neurochirurgie, printed on 31 October 2026 from databakkes.be/en/0739714179/dr-belinda-schrooten-neurochirurgie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Belinda Schrooten, Neurochirurgie from Waasmunster, company number BE0739714179, closed financial year 2025 with a result of € 28,385 after tax. For that financial year Dr. Belinda Schrooten, Neurochirurgie recorded a gross margin of € 38,652 and equity of € 125,113. Compared with financial year 2024, the result moved from € 31,087 to € 28,385. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 20, 2026.

What it is worth Healthy

€ 125,113

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,385

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,369

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 28,385 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 85 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 85

▲ 179% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 14,924

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,164

▲ 165% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,296

▼ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 76,778 Gross margin 2022: € 76,778 First fiscal year in the series	€ 61,355 Gross margin 2023: € 61,355 ▼ 20% vs 2022 (€ 76,778) Unfavourable step	€ 39,738 Gross margin 2024: € 39,738 ▼ 35% vs 2023 (€ 61,355) Unfavourable step	€ 38,652 Gross margin 2025: € 38,652 ▼ 3% vs 2024 (€ 39,738) Unfavourable step	▼ 3%
Profit after taxes	€ 54,636 Profit after taxes 2022: € 54,636 First fiscal year in the series	€ 48,205 Profit after taxes 2023: € 48,205 ▼ 12% vs 2022 (€ 54,636) Unfavourable step	€ 31,087 Profit after taxes 2024: € 31,087 ▼ 36% vs 2023 (€ 48,205) Unfavourable step	€ 28,385 Profit after taxes 2025: € 28,385 ▼ 9% vs 2024 (€ 31,087) Unfavourable step	▼ 9%
Equity	€ 125,113 Equity 2022: € 125,113 First fiscal year in the series	€ 125,113 Equity 2023: € 125,113 Unchanged (€ 125,113) Unchanged	€ 125,113 Equity 2024: € 125,113 Unchanged (€ 125,113) Unchanged	€ 125,113 Equity 2025: € 125,113 Unchanged (€ 125,113) Unchanged
Total debts	€ 11,119 Total debts 2022: € 11,119 First fiscal year in the series	€ 57,587 Total debts 2023: € 57,587 ▲ € 46,468 vs 2022 (€ 11,119) Unfavourable step	€ 36,405 Total debts 2024: € 36,405 ▼ 37% vs 2023 (€ 57,587) Favourable step	€ 36,845 Total debts 2025: € 36,845 ▲ 1% vs 2024 (€ 36,405) Unfavourable step	▲ 1%
Cash	€ 117,321 Cash 2022: € 117,321 First fiscal year in the series	€ 143,616 Cash 2023: € 143,616 ▲ 22% vs 2022 (€ 117,321) Favourable step	€ 133,041 Cash 2024: € 133,041 ▼ 7% vs 2023 (€ 143,616) Unfavourable step	€ 142,369 Cash 2025: € 142,369 ▲ 7% vs 2024 (€ 133,041) Favourable step	▲ 7%
Retained profit	€ 105,113 Retained profit 2022: € 105,113 First fiscal year in the series	€ 105,113 Retained profit 2023: € 105,113 Unchanged (€ 105,113) Unchanged	€ 105,113 Retained profit 2024: € 105,113 Unchanged (€ 105,113) Unchanged	€ 105,113 Retained profit 2025: € 105,113 Unchanged (€ 105,113) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 48,205 Dividend 2023: € 48,205 Unchanged (€ 0) Unchanged	€ 31,087 Dividend 2024: € 31,087 ▼ 36% vs 2023 (€ 48,205) Unchanged	€ 28,385 Dividend 2025: € 28,385 ▼ 9% vs 2024 (€ 31,087) Unchanged	▼ 9%
Balance sheet total	€ 136,232 Balance sheet total 2022: € 136,232 First fiscal year in the series	€ 182,700 Balance sheet total 2023: € 182,700 ▲ 34% vs 2022 (€ 136,232) Unchanged	€ 161,518 Balance sheet total 2024: € 161,518 ▼ 12% vs 2023 (€ 182,700) Unchanged	€ 161,959 Balance sheet total 2025: € 161,959 Unchanged (€ 161,518) Unchanged

Key figures of Dr. Belinda Schrooten, Neurochirurgie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Belinda Schrooten, Neurochirurgie?

What happened at Dr. Belinda Schrooten, Neurochirurgie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 20, 2026 New annual accounts for financial year 2025: profit of € 28,385 (▼ 9% vs 2024). Source: NBB ↗
Dec 17, 2019 New establishment in Waasmunster. KBO
Dec 17, 2019 Start of the company according to the CBE. KBO

In short

From € 54,636 profit in 2022 to € 28,385 profit in 2025.

Paid € 50,199 in corporate taxes since 2022.

Best year ever: 2022, with € 54,636 profit.

Paid out € 107,677 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Belinda Schrooten

Dr. Belinda Schrooten, Neurochirurgie

Behind Dr. Belinda Schrooten, Neurochirurgie is Belinda Schrooten.

Directors

According to the 2025 annual accounts

Belinda Schrooten

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Morgenster 7

9250 Waasmunster

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0739.714.179
VAT number: BE 0739.714.179
Registered office: Morgenster 7, 9250 Waasmunster
Names & denominations: Dr. Belinda Schrooten, Neurochirurgie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 December 2019
Peppol: Active · Active since 8 Apr 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗